Charles Vacanti
Charles Vacanti is an American anesthesiologist and tissue engineer known for his contributions to the field of regenerative medicine. He is particularly recognized for his work on the development of scaffolds for tissue engineering, and the controversial creation of a "vacanti mouse", a laboratory mouse that appeared to have a human ear grown on its back.
Early life and education[edit | edit source]
Charles Vacanti was born in the United States. He completed his undergraduate studies at the University of Nebraska and went on to earn his medical degree from the University of Minnesota. He completed his residency in anesthesiology at the Massachusetts General Hospital.
Career[edit | edit source]
Vacanti has held several academic and clinical positions throughout his career. He served as the Director of the Laboratory for Tissue Engineering and Regenerative Medicine at Brigham and Women's Hospital and was a Professor of Anesthesiology at Harvard Medical School.
Research[edit | edit source]
Vacanti's research has focused on the development of scaffolds for tissue engineering. These scaffolds provide a structure for cells to grow on, allowing for the creation of new tissues and organs. His work has been instrumental in the field of regenerative medicine, contributing to advances in treatments for conditions such as heart disease and liver disease.
One of Vacanti's most notable experiments involved the creation of a "vacanti mouse". This mouse, which appeared to have a human ear grown on its back, was created using a biodegradable scaffold in the shape of an ear, which was then seeded with cartilage cells. The experiment sparked controversy and ethical debates, but also highlighted the potential of tissue engineering.
Controversies[edit | edit source]
Vacanti has been involved in several controversies throughout his career. The most notable of these is his involvement in the STAP cells controversy. Vacanti and his team claimed to have discovered a new type of pluripotent stem cell, but their findings were later retracted due to issues with the research.
See also[edit | edit source]
References[edit | edit source]
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
